These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 15181051

  • 1. The investigation of insulin resistance in patients with idiopathic hirsutism.
    Unlühizarci K, Karababa Y, Bayram F, Kelestimur F.
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2741-4. PubMed ID: 15181051
    [Abstract] [Full Text] [Related]

  • 2. Assessment of insulin resistance in the idiopathic hirsutism.
    Sarac F, Saygili F, Ozgen G, Tuzun M, Yilmaz C, Kabalak T.
    Gynecol Obstet Invest; 2007 Jun; 63(3):126-31. PubMed ID: 17057397
    [Abstract] [Full Text] [Related]

  • 3. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
    Abdel Fattah NS, Darwish YW.
    Br J Dermatol; 2009 May; 160(5):1011-5. PubMed ID: 19298279
    [Abstract] [Full Text] [Related]

  • 4. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M, Papadavid E, Basios G, Vaggopoulos V, Rigopoulos D, Kassanos D, Trakakis E.
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [Abstract] [Full Text] [Related]

  • 5. Should insulin resistance be screened in lean hirsute women?
    Arduc A, Sarıcam O, Dogan BA, Tuna MM, Tutuncu YA, Isik S, Berker D, Sennaroglu E, Guler S.
    Gynecol Endocrinol; 2015 Apr; 31(4):291-5. PubMed ID: 25561024
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of insulin resistance in idiopathic hirsutism compared with polycystic ovary syndrome patients and healthy individuals.
    Bonakdaran S, Kiafar B, Barazandeh Ahmadabadi F.
    Australas J Dermatol; 2016 Feb; 57(1):e1-4. PubMed ID: 25496462
    [Abstract] [Full Text] [Related]

  • 7. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO, Yarali H, Oguz H, Bayraktar M.
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [Abstract] [Full Text] [Related]

  • 8. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S, Abrahami M, Lilos P, Phillip M.
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients.
    Ucak S, Basat O, Satir E, Altuntas Y.
    Endocr J; 2012 Jun; 59(4):291-6. PubMed ID: 22322894
    [Abstract] [Full Text] [Related]

  • 10. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [Abstract] [Full Text] [Related]

  • 11. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM.
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [Abstract] [Full Text] [Related]

  • 12. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Lal Khurana M, Seith A, Dwivedi SN, Kumar G, Ammini AC.
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance in women with hirsutism.
    Cebeci F, Onsun N, Mert M.
    Arch Med Sci; 2012 May 09; 8(2):342-6. PubMed ID: 22662009
    [Abstract] [Full Text] [Related]

  • 14. Hyperinsulinemia in polycystic ovary disease.
    Arthur LS, Selvakumar R, Seshadri MS, Seshadri L.
    J Reprod Med; 1999 Sep 09; 44(9):783-7. PubMed ID: 10509302
    [Abstract] [Full Text] [Related]

  • 15. Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A.
    J Clin Endocrinol Metab; 2002 Mar 09; 87(3):998-1003. PubMed ID: 11889151
    [Abstract] [Full Text] [Related]

  • 16. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
    Xiao J, Tian H, Li CL, Zhong WW, Sun BR, Li YP, Fang FS, Han XF, Liu YQ, Cheng XL.
    Zhonghua Nei Ke Za Zhi; 2012 Apr 09; 51(4):299-303. PubMed ID: 22781951
    [Abstract] [Full Text] [Related]

  • 17. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I.
    J Clin Endocrinol Metab; 2001 Oct 09; 86(10):4666-73. PubMed ID: 11600523
    [Abstract] [Full Text] [Related]

  • 18. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
    Bahceci M, Tuzcu A, Canoruc N, Tuzun Y, Kidir V, Aslan C.
    Horm Res; 2004 Oct 09; 62(6):283-7. PubMed ID: 15542929
    [Abstract] [Full Text] [Related]

  • 19. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec 09; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 20. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I, Algun E, Incecayir O, Ersoy K.
    Metab Syndr Relat Disord; 2011 Oct 09; 9(5):375-80. PubMed ID: 21657888
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.